MCRB - Seres Therapeutics, Inc.
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Annual
| Revenue | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 |
| Total Revenue | 32,100 | 21,766 | - | - |
| Cost of Revenue | 89,455 | 81,989 | 38,095 | 10,718 |
| Gross Profit | -57,355 | -60,223 | -38,095 | -10,718 |
| Operating Expenses | ||||
| Research Development | - | - | - | - |
| Selling General and Administrative | 34,040 | 32,616 | 16,761 | 4,364 |
| Non Recurring | - | - | - | - |
| Others | - | - | - | - |
| Total Operating Expenses | 123,495 | 114,605 | 54,856 | 15,082 |
| Operating Income or Loss | -91,395 | -92,839 | -54,856 | -15,082 |
| Income from Continuing Operations | ||||
| Total Other Income/Expenses Net | 2,015 | 1,260 | 76 | -1,627 |
| Earnings Before Interest and Taxes | -91,395 | -92,839 | -54,856 | -15,082 |
| Interest Expense | - | - | - | -209 |
| Income Before Tax | -89,380 | -91,579 | -54,780 | -16,709 |
| Income Tax Expense | - | - | - | - |
| Minority Interest | - | - | - | - |
| Net Income From Continuing Ops | -89,380 | -91,579 | -54,780 | -16,709 |
| Non-recurring Events | ||||
| Discontinued Operations | - | - | - | - |
| Extraordinary Items | - | - | - | - |
| Effect Of Accounting Changes | - | - | - | - |
| Other Items | - | - | - | - |
| Net Income | ||||
| Net Income | -89,380 | -91,579 | -54,780 | -16,709 |
| Preferred Stock And Other Adjustments | - | - | - | - |
| Net Income Applicable To Common Shares | -89,380 | -91,579 | -54,780 | -18,000 |
